ggwpq, you’re right about the insurers. They have been the biggest obstacle to accelerated uptake and use of Vascepa through lack of coverage, poor tiering and very high copays. Lack of patient and doctor awareness haven’t helped either. Many other obstacles and headwinds have hampered growth too. The past has been brutal but I feel like the tides are changing in our favor.
News 
Market Data 
Discover 
AI
